Mortality [qnco]
Myocardial [spco]
Response [orga]
Variability [cnce]
Antiarrhythmic drug [phsu]
therapy [ftcn]
objectives [inpr]
Study [mnob]
Design [acty]
Test [lbpr]
Hypothesis [idcn]
Antiarrhythmic Drugs [phsu]
Decrease [qlco]
Variability [cnce]
Mortality [qnco]
Myocardial Infarction [dsyn]
Variability [cnce]
Non-invasive [ftcn]
indicator [irda]
Autonomic nervous system [bdsy]
activity [dora]
Acute myocardial infarction [dsyn]
Response [orga]
Drugs [phsu]
Previous [tmco]
Study [mnob]
Patients [podg]
Chronic heart disease [dsyn]
Ventricular Premature Complexes [patf]
Reported [inpr]
Flecainide [orch, phsu]
Decreased [qnco]
Modulation [spco]
RR interval [clna]
Amiodarone [orch, phsu]
Investigators [prog]
Study [mnob]
Variability [cnce]
Antiarrhythmic drug [phsu]
therapy [ftcn]
Increased [qnco]
Mortality rate [qnco]
long-term treatment [hlca]
Drug [phsu]
Hypothesis [idcn]
Compared [acty]
effects [qlco]
Encainide [orch, phsu]
Flecainide [orch, phsu]
Mortality [qnco]
Variability [cnce]
effects [qlco]
placebo [topp]
Moricizine [orch, phsu]
Mortality [qnco]
long-term treatment [hlca]
Ventricular arrhythmias [patf]
Myocardial Infarction [dsyn]
Methods [inpr]
H+ [elii]
Power [hcpp]
Spectral [qnco]
density [qnco]
Computed [lbpr]
baseline [bodm]
electrocardiograph [fndg]
Drug Evaluation [resa]
tapes [medd]
Six [qnco]
frequency [qnco]
Domain [ftcn]
Measure [qnco]
Variability [cnce]
Calculated [ftcn]
ultra [medd]
Low frequency [tmco]
Hz [qnco]
Very low [fndg]
frequency [qnco]
Hz [qnco]
Low frequency [tmco]
Hz [qnco]
High frequency [tmco]
Power [hcpp]
Hz [qnco]
Plus [qlco]
Power [hcpp]
Hz [qnco]
Ratio [qnco]
High frequency [tmco]
Power [hcpp]
Power [hcpp]
Spectral [qnco]
Measures [qnco]
Drug [phsu]
treatment [ftcn]
Mortality [qnco]
placebo [topp]
Group [idcn]
Values [qlco]
R-R interval [clna]
Variability [cnce]
Increased [qnco]
Recovery [acty]
effects [qlco]
Acute myocardial infarction [dsyn]
contrasting [diap]
placebo [topp]
treatment [ftcn]
Active Treatment [topp]
Antiarrhythmic drug [phsu]
Taken [cnce]
Together [qlco]
AH [dsyn]
Measures [qnco]
Variability [cnce]
Low frequency [tmco]
Power [hcpp]
Changed [ftcn]
Drug [phsu]
treatment [ftcn]
Adjusted [ftcn]
P-Value [qnco]
variables [qlco]
Decreased [qnco]
Drug Therapy [topp]
contrasting [diap]
Encainide [orch, phsu]
Flecainide [orch, phsu]
Moricizine [orch, phsu]
Encainide [orch, phsu]
Flecainide [orch, phsu]
Group [idcn]
Taken [cnce]
Together [qlco]
larger [qnco]
Decrease [qlco]
Moricizine [orch, phsu]
Borderline [qlco]
Adjusted [ftcn]
P-Value [qnco]
Survival [acty]
worse [qlco]
Group [idcn]
treated [topp]
Encainide [orch, phsu]
Flecainide [orch, phsu]
Group [idcn]
treated [topp]
placebo [topp]
Moricizine [orch, phsu]
Relative Risk [qnco]
Adjusted [ftcn]
P NOS [aapp, imft]
Antiarrhythmic drug [phsu]
Induced [ftcn]
Measures [qnco]
Variability [cnce]
Mortality [qnco]
Myocardial Infarction [dsyn]
Conclusions [idcn]
Encainide [orch, phsu]
Flecainide [orch, phsu]
Moricizine [orch, phsu]
Decrease [qlco]
Variability [cnce]
Patients [podg]
Study [mnob]
1 Month [tmco]
Acute myocardial infarction [dsyn]
Encainide [orch, phsu]
Flecainide [orch, phsu]
mortality rates [qnco]
placebo [topp]
Moricizine [orch, phsu]
baseline [bodm]
measurements [ftcn]
Variability [cnce]
Predicted [idcn]
Mortality [qnco]
Myocardial Infarction [dsyn]
Decrease [qlco]
Variability [cnce]
Antiarrhythmic Drugs [phsu]
Mortality [qnco]
